Amend CSHB 1 (house committee report) in Article I of the bill, following the appropriations to the Cancer Prevention and Research Institute of Texas (page I-16), by adding the following appropriately numbered rider and renumbering subsequent riders accordingly:

____.  Contingent Rider: Cancer Clinical Trial Participation Program. Contingent on the passage and becoming law of HB 3147 or similar legislation of the 86th Legislature, Regular Session, 2019, relating to a cancer clinical trial participation program, out of amounts appropriated above to the Cancer Prevention and Research Institute of Texas, the institute may allocate money in accordance with Chapter 102, Health and Safety Code, for the purpose of providing reimbursement for cancer clinical trial participation under the program described by that legislation.